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Edited by Lukas HuberAbstract While long-term eﬀects of temperature treatment in
respect of, e.g., gene-expression and cellular function have
already been studied in some detail, nothing is known on the
physiological responses of lymphocytes during short-term hypo-
thermal shifts. In this report, we characterized the eﬀects of such
a stimulation using the human lymphocyte cell line Jurkat E6.1
and present evidence that warming from 4 to 37 C for only 2
min is suﬃcient to cause co-localization of CD3, prion protein
and the lipid-raft ganglioside GM1 paralleling lymphocyte
activation as observed by Ca2þ mobilization and mitogen-
activated protein kinase-phosphorylation.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The activation of T-lymphocytes occurs primarily through
the well-characterized mechanism of antigen-mediated T-cell
receptor (TCR) clustering [1]. However, secondary priming
routes like the stimulation through cytokines or unspeciﬁc
stress-signals (e.g., temperature, oxidative stress and irradia-
tion) are gaining increasing interest [2–4]. The earliest de-
tectable biochemical events after lymphocyte activation
include rapid tyrosine phosphorylation of multiple intracel-
lular proteins leading to the triggering of downstream sig-
naling pathways [5]. These include, but are not limited to,
hydrolysis of inositol-containing phospholipids, Ca2þ mobi-
lization and activation of the mitogen-activated protein
kinase (MAPK) pathways [6]. Immediate responses of lym-
phocytes following speciﬁc stimulation like the appearance of
an immunological synapse or the secretion of lymphokines
have been studied extensively in terms of the above-men-
tioned signal transduction cascades (for reviews see [7,8]).
Yet, experiments using unspeciﬁc stimulation through tem-* Corresponding author. Fax: +43-732-606079-30.
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term eﬀects and investigated the response of lymphocytes in
respect of, e.g., proliferative outcome, lymphokine production
or alterations in gene expression patterns [9,10]. For instance,
the down-regulation of TCR-f chain expression in lympho-
cytes and the up-regulation of heat-shock protein 70 as well
as prion protein (PrP) expression in human NT-2 cells have
been reported [11–13].
The aim of our work was to study the early responses of
lymphocytes following hypothermal stimulation. Such treat-
ments have relevance in a variety of applications, ranging from
the areas of transplantation and critical care medicine into the
experimental ﬁeld of designing cellular assay systems. While
the physiological eﬀects of the ﬁrst are only beginning to be
studied in more detail, the incubation of cells at low temper-
atures is a standard procedure in cell biology. We have selected
the CD3-subunit of the TCR-complex as an exemplary pro-
tein necessary for ligand-speciﬁc lymphocyte activation and
investigated its behavior during hypothermal treatment. In
addition, the glycosylphosphatidylinositol (GPI)-anchored PrP
was chosen because of its preferential localization in lipid-raft
microdomains and due to its possible roles during T-lympho-
cyte activation [14–16] (for reviews see [17–19]). We have fo-
cused on early events following hypothermal stimulation in
terms of reallocation of the selected proteins into aggregating
membrane domains as well as cell-activation in respect of Ca2þ
mobilization and MAPK/stress-activated protein kinase
(SAPK)-phosphorylation.2. Materials and methods
2.1. Cell culture, reagents and antibodies
The human T-cell lymphoma cell line Jurkat E6.1 was cultured in
RPMI-medium containing 10% heat-inactivated fetal bovine serum
(Summit BiotechnologyTM), 2 mM L-glutamine, 100 U/ml penicillin
and 100 lg/ml streptomycin (all reagents GIBCOTM, Invitrogen Co-
operation). The enhanced chemiluminescence (ECL) detection kit and
ﬂuorescent labeled secondary antibodies were from Amersham Bio-
sciences. Mouse monoclonal anti-PrP antibody (SAF-32) was pur-
chased from Cayman Chemical, mouse monoclonal anti-CD3
antibody and Alexa Fluor 647-labeled anti-CD3 Fab-fragments were
gifts from Dr. H. Stockinger (Institute of Immunology, University of
Vienna, Austria). Calcium Green-1, Alexa Fluor 488-labeled trans-
ferrin and Alexa Fluor 647-labeled cholera toxin subunit B (CT-B)
conjugate were from Molecular Probes Inc., methyl-b-cyclodextrin
(MbCD), cytochalasin D (Cyt D) and all other antibodies were from
SIGMA.blished by Elsevier B.V. All rights reserved.
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life cell imaging
Cells growing in log-phase were adjusted to a concentration of
7 106 cells/ml in Opti-MEM I medium (GIBCOTM) and incubated
on ice for 30 min. After warming to 37 C for 2 min (except indicated
otherwise), cells were ﬁxed in 3.7% formaldehyde in PBS for 15 min at
RT and spun onto poly-L-lysine-coated cover glasses (Cytospin,
Thermo Shandon Inc.). For cell surface staining of the ganglioside
GM1, cells were incubated with 1 lg/ml Alexa Fluor 647-labeled CT-B
in PBS for 15 min at RT. After washing with PBS, cover glasses were
sealed using HybriWellTM chambers (GRACE Bio-Labs Inc.). Cell
surface transferrin receptor was stained with 100 lg/ml Alexa Fluor
488-labeled transferrin in 1% BSA/PBS for 30 min at 37 C on cells
depleted of endogenous transferrin by serum starvation for 45 min at
37 C in HBSS. For cell surface staining of PrP and CD3, cells were
blocked with 2% BSA/PBS for 20 min and incubated with the ap-
propriate primary antibodies (anti-PrP 0.2 lg/ml; anti-CD3 5 lg/ml)
for 30 min. After incubation with Cy3-labeled secondary antibodies
(1:2000) for 30 min, samples were sealed as described above. For life
cell imaging of intracellular free Ca2þ, cells were incubated with 10 lM
Calcium Green-1 in normal growth medium for 15 min at 37 C, fol-
lowed by incubation with Alexa Fluor 647-labeled anti-CD3 Fab-
fragments (5 lg/ml) for 30 min at 4 C. After washing cells in ice-cold
HBSS they were ﬂushed into a perfusion chamber prewarmed to 37 C.
Ca2þ images were acquired every 2 s and cap formation was veriﬁed by
CD3 cell surface distribution 2–3 min after start of experiments.
2.3. SDS–PAGE and Western blot analysis
Western blot analysis was performed as described earlier [20]. Equal
amounts of protein were subjected to 10% SDS–polyacrylamide gel
electrophoresis and transferred to PVDF membranes (ImmobilonTM-
P; Millipore Corporation). After blocking in PBS containing 0.1%
Tween 20 and 5% non-fat dry milk for 1 h, membranes were incubated
with the appropriate primary antibodies overnight at 4 C at the di-
lution suggested by the supplier. Following incubation with peroxidase
conjugated secondary antibodies for 1 h, signal was developed by use
of the ECL reagent (Amersham Biosciences).
2.4. Inhibition experiments
Raft structures were disturbed by treatment with 4 mM MbCD for
40 min at 37 C prior to hypothermal stimulation. Viability of cells was
tested by trypan blue exclusion staining. No signiﬁcant cell death was
detected after cholesterol extraction (data not shown). For disruption
of the actin–cytoskeleton, cells were preincubated with 10 lM Cyt D
for 20 min in Opti-MEM I medium prior to hypothermal treatment.
2.5. Fluorescence microscopy and image processing
To analyze large populations of Jurkat E6.1 cells in these experi-
ments, we utilized a self-developed ﬂuorescence screening system
(CytoScout, Upper Austrian Research GmbH). The system is based
on a conventional epi-ﬂuorescence microscope (Axiovert 200, Zeiss)
using wide ﬁeld illumination and a motorized scanning stage
(M€arzh€auser GmbH). Scans of usually 1 1 mm allowed for repre-
sentative analysis of our experiments and were facilitated by a special
read-out mode (patent pending; for details see [21]). Image processing
was based on a pattern matching algorithm programmed in C++ using
the Matrox Imaging Library (Matrox Electronic Systems Ltd.). For
analysis, a typical cap was selected as a template and parameters of the
algorithm were adjusted such that a good agreement of identiﬁed caps
with numbers obtained by visual inspection was achieved. Experiments
were repeated at least three times (statistical analysis by Student’s t-
test) and results of representative experiments are shown in the ﬁgures.Fig. 1. Clustering of GM1-rich domains after hypothermal stimula-
tion. (A) Eﬀects of temperature shifts. Cells were incubated at the in-
dicated temperatures for 30 min, warmed to 37 C for 2 min, ﬁxed and
stained for cell surface GM1 with Alexa Fluor 647-labeled CT-B.
Fluorescence images were analyzed for the number of caps in relation
to the whole cell number (% in brackets). (B) Time course of cap
formation. Cells were incubated at 4 C for 30 min, warmed to 37 C
for the times indicated and analyzed as described above. Representa-
tive cells are magniﬁed. Bar, 20 lm.3. Results
3.1. Clustering of GM1-rich microdomains is induced by
hypothermal stimulation
We studied the distribution of the raft-enriched glyco-
sphingolipid GM1 in Jurkat E6.1 cells during hypothermal
treatment. GM1 is evenly distributed on the plasma membrane
of untreated cells or cells incubated at 4 C only, whereas atemperature shift from 4 to 37 C leads to the formation of
cap-like structures enriched in GM1 in approximately 30 2%
of cells (P < 0:0001 versus control 5.5 2.6%; Fig. 1A). Also
lesser temperature diﬀerences were tested. Incubation at 12 C
for 30 min prior to 37 C warming was still suﬃcient to induce
membrane aggregation in 21% of the cells. When the temper-
ature was changed from 20 or 28 to 37 C, almost no cap-
structures could be detected (9% and 10%, respectively). First
reorganization of the plasma membrane can be observed al-
ready 1 min after temperature change (Fig. 1B). Cap-like
structures are fully developed after 2 min and disappear when
the 37 C incubation period is prolonged.
3.2. Co-localization of CD3 and PrP with GM1
To further characterize these temperature-induced struc-
tures, we investigated the distribution of the TCR-component
CD3 as well as the GPI-linked membrane protein PrP on the
membrane of stimulated lymphocytes. In control experiments,
ﬂuorescent labeled transferrin was used to study the distribu-
tion of the transferrin receptor, a non-raft molecule. Following
incubation at 4 C for 30 min and warming to 37 C for 2 min,
CD3 and PrP co-localized in fully developed GM1-rich cap-
structures. In contrast, transferrin remained evenly distributed
over the whole cell surface, providing evidence for a reorga-
nization of raft microdomains (Fig. 2).
3.3. Activation of the MAPK-pathway by hypothermal
stimulation
To investigate whether cap-formation is associated with the
activation of signal transduction cascades, we tested the
Fig. 4. Inﬂuence of cholesterol and actin on temperature-induced cap-
formation. (A) Depletion of cellular cholesterol with MbCD. Cells
were maintained without (Co), or with 4 mM MbCD at 37 C for 40
min prior to hypothermal treatment and stained for GM1 as described
in Section 2. (B) Disruption of the actin cytoskeleton by Cyt D. Cells
were incubated without (Co), or with 10 lMCyt D for 20 min at 37 C
and stained for GM1. (C) Cells were incubated without (Co), or pre-
treated either with MbCD or Cyt D as described above, washed, in-
cubated at 4 C for 30 min ()) or subsequently warmed to 37 C for 2
min (+). Cell lysates were prepared and analyzed by immunoblotting
with the indicated antibodies. Bar, 20 lm.
Fig. 2. Co-localization of CD3 and PrP with GM1-rich domains. Cells
stimulated by hypothermal treatment were ﬁxed and stained for (A)
GM1 (red) and CD3 (green), (B) GM1 (red) and PrP (green) and (C)
GM1 (red) and transferrin (green) as described in Section 2. Shown is
the ﬂuorescence image of a representative cell (left and middle column)
as well as the merge of the two signals (right column). Bar, 5 lm.
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p44/42 MAPK, SAPK and p38 MAPK. Activation of MAPKs
was determined by immunoblotting using antibodies speciﬁc
for the phosphorylated forms of the respective enzymes. Total
levels of endogenous p44/42 MAPK were used as a control for
equal loading. Maximal p44/42 MAPK phosphorylation was
obtained already after 1 min of 37 C treatment following
hypothermal stimulation, reaching basal levels again after 10
min (Fig. 3). In contrast, no phospho-SAPKs or phospho-p38
MAPKs were detected (data not shown). The time course of
p44/42 MAPK activation mirrors that of cap formation
(compare Figs. 1B and 3).
3.4. Inhibition of capping by treatment with MbCD or Cyt D
To determine the necessity of intact lipid-raft structures
during hypothermal treatment, Jurkat E6.1 cells were de-
pleted of cellular cholesterol by incubation with 4 mM
MbCD [22]. Subsequently, cells were stimulated as described
above and stained for GM1. Formation of cap-structures was
abolished completely in Jurkat E6.1 cells pretreated with
MbCD (Fig. 4A) indicating that intact lipid rafts are essential
for reallocation of the selected proteins. In contrast, p44/42
MAPK phosphorylation was not impaired as shown in
Fig. 4C. We also investigated whether an intact actin cyto-
skeleton is required for the formation of cap-like structures.Fig. 3. Activation of the MAPK-pathway by hypothermal treatment.
Cells were treated as described in Fig. 1B and cell lysates were im-
munoblotted with anti-phospho-p44/42 (upper panel) and anti-p44/42
antibodies (lower panel) as described in Section 2.Incubation of Jurkat E6.1 cells with 10 lM Cyt D preceding
hypothermal stimulation prevented the capping process
(Fig. 4B). A possible inﬂuence of the cytoskeleton on the
hypothermal activation could not be studied because Cyt D
alone caused high levels of phosphorylated p44/42 MAPK
(Fig. 4C).
3.5. Ca2þ mobilization by hypothermal treatment
Cell activation following hypothermal treatment was also
investigated by monitoring the intracellular free Ca2þ con-
centration with Calcium Green-1. Fig. 5 shows the typical
results of such a life cell imaging experiment. After hypother-
mal treatment, we could observe Ca2þ oscillations exclusively
in cells developing a cap-like structure.4. Discussion
Exposure to environmental stress, like hypo-/hyperthermia,
reactive oxygen species or inﬂammatory cytokines, represents
unavoidable events for almost all cell-types. While this may
lead to structural damage such as protein denaturation, it can
in the same turn induce a physiological response like cell ac-
tivation and stress protein synthesis [23]. In this study, we
utilized ﬂuorescence microscopy to visualize the earliest mor-
phological events following temperature-induced stimulation
of Jurkat E6.1 human lymphocyte cells.
Fig. 5. Ca2þ mobilization after hypothermal treatment. Cells were la-
beled with Calcium Green-1 and anti-CD3 Fab as described in Section
2. Following incubation at 4 C for 30 min, cells were ﬂushed into a
perfusion chamber prewarmed to 37 C. Ca2þ oscillations induced by
hypothermal stimulation are shown in (A) and (B), respectively. High
Ca2þ concentrations are indicated in red. Only cells developing a cap-
structure (C) exhibit an increase in intracellular free Ca2þ levels (B).
Bar, 5 lm.
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cytes, contain microdomains commonly referred to as lipid
rafts. They are biochemically distinct from bulk plasma
membrane, are enriched in sphingolipids and cholesterol and
contain, e.g., membrane proteins attached to the outer surface
via a GPI-moiety or intracellular proteins such as dually ac-
ylated Src-family kinase members [24,25] (for review see [26]).
To study the distribution of lipid rafts before, during and after
hypothermal activation, we used ﬂuorescent labeled CT-B,
which binds to the GM1 ganglioside in the outer leaﬂet of the
plasma membrane. Besides being useful markers for lipid-raft
membrane microdomains, gangliosides such as GM1 or GM3
have been described in several cell lines to be co-localized with
PrP [27–29]. In addition, raft association has been shown to be
essential for membrane protein redistribution in polarized T
cells [30]. Lipid rafts are shown as small patches scattered
randomly all over the surface of unstimulated cells which co-
alesce into one or a few aggregated patches in response to
hypothermal stimulation, a process similar to the actin-medi-
ated reorganization at an immunological synapse followingantigen-mediated lymphocyte activation [31]. Formation of
such cap-structures was dependent on the temperature-diﬀer-
ences used for stimulation with an incubation-shift from 4 to
37 C yielding the highest degree of activation (see Fig. 1A).
First reorganization of plasma membrane domains could be
seen after less then 1 min and lasted for approximately 5–10
min (see Fig. 1B). Even hypothermal treatment at 4 C for only
10 min proved suﬃcient to detect lymphocyte activation after 2
min at 37 C (data not shown). Characterization of fully de-
veloped cap-structures showed a strict co-localization of CD3
and PrP but not transferrin in GM1-rich domains (see Fig. 2).
Although immunoprecipitation experiments performed by our
group have not been able to conﬁrm a direct association be-
tween CD3 and PrP, recent reports have revealed that PrP is
able to form a stable complex with ZAP-70 kinase, a compo-
nent of the multimolecular TCR-signaling complex formed
during T-cell activation [29].
Although much eﬀort has been made to elucidate signal
transduction events induced by speciﬁc stimulation of
lymphocytes via antigen-presenting cells, only few data are
available on the initial mechanisms occurring after tempera-
ture-induced lymphocyte activation. The most feasible sce-
nario speciﬁes the plasma membrane itself as being the primary
sensor for temperature alterations. This could be due to the
diﬀerent ﬂuidic states a membrane acquires at variable tem-
peratures, like rigidiﬁcation at low temperatures and ﬂuidiza-
tion during heat-activation (for reviews see [32,33]). A direct
inﬂuence of changing membrane properties on receptor kinase
behavior is conceivable. Signal transduction through the
MAPK pathway is usually initiated by ligand-induced receptor
dimerization and subsequent auto-phosphorylation. The acti-
vation of MAPK (as shown in Fig. 3) and not SAPK/p38 (data
not shown) during hypothermal stimulation indicates that we
do not induce a classical heat-shock stress-response but rather
stimulate lymphocytes via a classical, receptor-clustering route.
This might be induced through restricted diﬀusion of receptor
tyrosine kinases in the rigidiﬁed plasma membrane increasing
or stabilizing potential receptor dimerization/clustering events
followed by the subsequent activation of signal transduction
cascades. In addition, also a process involving the inactiva-
tion of phosphatases seems plausible and awaits further
characterization [34].
Hypothermal activation is impaired in T-cells after depletion
of membrane cholesterol by MbCD (see Fig. 4A). This treat-
ment was shown to eﬃciently disturb lipid-raft microdomains
thereby interfering with the proper sorting of GPI-anchored
proteins [35]. A similar eﬀect was obtained in T-cells treated
with Cyt D, an agent which disrupts the actin cytoskeleton
[36]. As shown in Fig. 4B, we have been able to abolish for-
mation of GM1-rich structures by this compound. These data
indicate that an intact membrane morphology as well as an
undamaged cytoskeleton are indispensable for proper lym-
phocyte activation also in the process of hypothermal stimu-
lation of cells.
Furthermore, temperature-induced stimulation proved suf-
ﬁcient to evoke an increase in intracellular free Ca2þ concen-
trations, one of the obligatory events during T-cell activation
(Fig. 5). This corroborates our ﬁnding that hypothermal
treatment represents indeed a novel route to induce cellular
activation in a standardized and accurately described lym-
phocyte cell line. Current work is in progress to investigate
hypothermal treatment in other cells of lymphoid origin as well
S. Wurm et al. / FEBS Letters 566 (2004) 121–125 125as primary lymphocyte cultures to eventually study the
physiological relevance of our observations under in vivo
conditions.
In summary, our results demonstrate that exposure of Jur-
kat E6.1 lymphocyte cells to moderate temperature stress leads
to a transient activation of the MAPK-signal transduction
cascade with concomitant co-localization of CD3 and PrP in
GM1-enriched membrane lipid-raft structures. This activation
was conﬁrmed by life cell imaging experiments showing Ca2þ
mobilization following hypothermal treatment. Our results
demonstrate for the ﬁrst time, that hypothermal stimulation is
suﬃcient to trigger the default appearance of an immunolog-
ical synapse-like structure on a lymphocyte cell line. Co-lo-
calization was dependent on the presence of plasma membrane
cholesterol and on an intact actin cytoskeleton. Temperature-
induced activation persisted for 10 min and did not lead to
the phosphorylation of SAPKs, implying a process diﬀerent
from a conventional heat-shock stress-response.
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